Alan Prem Kumar (Alan P Kumar)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 62

Top Topics

Signaling Pathway

Top Venues

International journal of molecular sciences

Bioengineering & translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Milad Ashrafizadeh, Chakrabhavi D Mohan, Shobith Rangappa, Ali Zarrabi, Kiavash Hushmandi, Alan Prem Kumar, Gautam Sethi, Kanchugarakoppal Subbegowda Rangappa
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response. Medicinal research reviews (2023)
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K Shanmugam, Hin Chong Leong, Pooyan Makvandi, Kanchugarakoppal Subbegowda Rangappa, Anupam Bishyaee, Alan Prem Kumar, Gautam Sethi
Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Medicinal research reviews (2023)
Xin Yuan Lim, Sharah Mae Capinpin, Nagarjun Bolem, Aaron Song Chuan Foo, Wai-Cheong George Yip, Alan Prem Kumar, Daniel Boon Loong Teh
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme. Bioengineering & translational medicine 8 (3) (2023)
Jannah Binte Mohamed Kamarudin, Bowen Sun, Aaron Song Chuan Foo, Xin-Yuan Lim, Heevah Judd, Xingfei Tan, Xuan Hao Tan, Rafhanah Banu Binte Abdul Razar, Min Liu, Jinglin Zhong, John Jia En Chua, Celene Wei Qi Ng, James C H Goh, Tuan Zea Tan, Bhav Harshad Parikh, Xinyi Su, Alan Prem Kumar, Wei Yi Ong, Naoki Yamaguchi, Sze Y Set, Wai-Cheong George Yip, Jing Zhang, Daniel Boon Loong Teh
SIRIUS, Ultra-Scintillating Upconversion Breast Implant for Remote Orthotopic Photodynamic Therapy. ACS nano (2023)
Xin Yuan Lim, Sharah Mae Capinpin, Nagarjun Bolem, Aaron Song Chuan Foo, Wai-Cheong George Yip, Alan Prem Kumar, Daniel Boon Loong Teh
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme. Bioengineering & translational medicine 8 (3) (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K Shanmugam, Hin Chong Leong, Pooyan Makvandi, Kanchugarakoppal Subbegowda Rangappa, Anupam Bishyaee, Alan Prem Kumar, Gautam Sethi
Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Medicinal research reviews (2023)
Xin Yuan Lim, Sharah Mae Capinpin, Nagarjun Bolem, Aaron Song Chuan Foo, Wai-Cheong George Yip, Alan Prem Kumar, Daniel Boon Loong Teh
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme. Bioengineering & translational medicine 8 (3) (2023)
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, Mohammad Hossein Gholami, Kiavash Hushmandi, Mehrdad Hashemi, Azuma Kalu, Ali Zarrabi, Noushin Nabavi, Navid Rabiee, Esmaeel Sharifi, Hassan Karimi-Maleh, Milad Ashrafizadeh, Alan Prem Kumar, Yuzhuo Z Wang
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Manoj Kumar, Kuldeep Dhama, E Hui Clarissa Lee, Kenneth Chun-Yong Yap, Sharah Mae Capinpin, Alan Prem Kumar
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends. Biomolecules 13 (1) (2022)
Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh, Alan Prem Kumar
The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of hematology & oncology 15 (1) (2022)
Shailendra Kumar Gangwar, Aviral Kumar, Kenneth Chun-Hong Yap, Sandra Jose, Dey Parama, Gautam Sethi, Alan Prem Kumar, Ajaikumar B Kunnumakkara
Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh, Alan Prem Kumar
Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of hematology & oncology 15 (1) (2022)
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Hossein Gholami, Ali Zarrabi, Farid Hashemi, Kiavash Hushmandi, Mehrdad Hashemi, Noushin Nabavi, Francesco Crea, Jun Ren, Daniel J Klionsky, Alan Prem Kumar, Yuzhuo Z Wang
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Shuo Deng, Hin Chong Leong, Arpita Datta, Vennila Gopal, Alan Prem Kumar, Celestial T Yap
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression. Cancers 14 (7) (2022)
Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Manoj Kumar, Kuldeep Dhama, E Hui Clarissa Lee, Kenneth Chun-Yong Yap, Sharah Mae Capinpin, Alan Prem Kumar
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends. Biomolecules 13 (1) (2022)
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, Ali Zarrabi, Ebrahim Mostafavi
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. International journal of nanomedicine 17 (2022)
Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, Kiavash Hushmandi, Amirhossein Zabolian, Pooria Bikarannejad, Mehrdad Hashemi, Salman Daneshi, Sepideh Mirzaei, Esmaeel Sharifi, Alan Prem Kumar, Haroon Khan, Hamid Heydari Sheikh Hossein, Massoud Vosough, Navid Rabiee, Vijay Kumar Thakur, Giuseppe Perale, Yogendra Kumar Mishra, Franklin R Tay, Yuzhuo Z Wang, Ali Zarrabi, Gorka Orive, Ebrahim Mostafavi
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance. Expert opinion on drug delivery 19 (4) (2022)
Milad Ashrafizadeh, Ali Zarrabi, Hassan Karimi-Maleh, Afshin Taheriazam, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Giuseppe Perale, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Arul Goel, Lingzhi Wang, Jun Ren, Yavuz Nuri Ertas, Alan Prem Kumar, Yuzhuo Z Wang, Navid Rabiee, Gautam Sethi, Zhaowu Ma
(Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering & translational medicine 8 (1) (2022)
Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Manoj Kumar, Kuldeep Dhama, E Hui Clarissa Lee, Kenneth Chun-Yong Yap, Sharah Mae Capinpin, Alan Prem Kumar
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends. Biomolecules 13 (1) (2022)
Sujitha Jayaprakash, Mangala Hegde, Sosmitha Girisa, Mohammed Saeed Alqahtani, Mohamed Abbas, E Hui Clarissa Lee, Kenneth Chun-Hong Yap, Gautam Sethi, Alan Prem Kumar, Ajaikumar B Kunnumakkara
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer. International journal of molecular sciences 23 (18) (2022)
Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Anuj Ranjan, Seema Ramniwas, Katrin Sak, Diwakar Aggarwal, Manoj Kumar, Kuldeep Dhama, E Hui Clarissa Lee, Kenneth Chun-Yong Yap, Sharah Mae Capinpin, Alan Prem Kumar
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends. Biomolecules 13 (1) (2022)
Shefa Mirani Nezhad, Ehsan Nazarzadeh Zare, Azimeh Davarpanah, Seied Ali Pourmousavi, Milad Ashrafizadeh, Alan Prem Kumar
Ionic Liquid-Assisted Fabrication of Bioactive Heterogeneous Magnetic Nanocatalyst with Antioxidant and Antibacterial Activities for the Synthesis of Polyhydroquinoline Derivatives. Molecules (Basel, Switzerland) 27 (5) (2022)
Young Yun Jung, Chakrabhavi Dhananjaya Mohan, Huiyan Eng, Acharan S Narula, Ojas A Namjoshi, Bruce E Blough, Kanchugarakoppal S Rangappa, Gautam Sethi, Alan Prem Kumar, Yeong Shik Kim
2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells. Biomolecules 12 (7) (2022)
Milad Ashrafizadeh, Ali Zarrabi, Hassan Karimi-Maleh, Afshin Taheriazam, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Giuseppe Perale, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Arul Goel, Lingzhi Wang, Jun Ren, Yavuz Nuri Ertas, Alan Prem Kumar, Yuzhuo Z Wang, Navid Rabiee, Gautam Sethi, Zhaowu Ma
(Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering & translational medicine 8 (1) (2022)
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Soodeh Hamzehlou, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Milad Ashrafizadeh, Haroon Khan, Alan Prem Kumar
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants (Basel, Switzerland) 10 (3) (2021)
Ali Dehshahri, Alessio Biagioni, Hadi Bayat, E Hui Clarissa Lee, Mohammad Hashemabadi, Hojjat Samareh Fekri, Ali Zarrabi, Reza Mohammadinejad, Alan Prem Kumar
Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. International journal of molecular sciences 22 (21) (2021)
Hossein Maleki-Ghaleh, M Hossein Siadati, Ali Fallah, B Koc, Majid Kavanlouei, P Khademi-Azandehi, E Moradpur-Tari, Y Omidi, J Barar, Younes Beygi-Khosrowshahi, Alan Prem Kumar, K Adibkia
Antibacterial and Cellular Behaviors of Novel Zinc-Doped Hydroxyapatite/Graphene Nanocomposite for Bone Tissue Engineering. International journal of molecular sciences 22 (17) (2021)
Asal Jalal Abadi, Ali Zarrabi, Mohammad Hossein Gholami, Sepideh Mirzaei, Farid Hashemi, Amirhossein Zabolian, Maliheh Entezari, Kiavash Hushmandi, Milad Ashrafizadeh, Haroon Khan, Alan Prem Kumar
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules 11 (2) (2021)
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, Alan Prem Kumar, Markus Schweipert, Franz-Josef Meyer-Almes, Ramaa C S
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks. RSC medicinal chemistry 12 (9) (2021)
Ser Yue Loo, Nicholas Li-Xun Syn, Angele Pei-Fern Koh, Janet Cheng-Fei Teng, Amudha Deivasigamani, Tuan-Zea Tan, Aye Aye Thike, Shireen Vali, Shweta Kapoor, Xiaoyuan Wang, Jiong-Wei Wang, Puay Hoon Tan, George W Yip, Gautam Sethi, Ruby Yun-Ju Huang, Kam Man Hui, Lingzhi Wang, Boon Cher Goh, Alan Prem Kumar
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell death discovery 7 (1) (2021)
Arpita Datta, Shuo Deng, Vennila Gopal, Kenneth Chun-Hong Yap, Clarissa Esmeralda Halim, Mun Leng Lye, Mei Shan Ong, Tuan-Zea Tan, Gautam Sethi, Shing Chuan Hooi, Alan Prem Kumar, Celestial T Yap
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. Cancers 13 (8) (2021)
Hiu Yan Lam, Vinay Tergaonkar, Alan Prem Kumar, Yeong Shik Kim
Mast cells: Therapeutic targets for COVID-19 and beyond. IUBMB life 73 (11) (2021)
Loukik Arora, Chakrabhavi Dhananjaya Mohan, Min Hee Yang, Shobith Rangappa, Amudha Deivasigamani, Alan Prem Kumar, Ajaikumar B Kunnumakkara, Manoj Garg, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Tahani Awad Alahmadi, Kanchugarakoppal S Rangappa, Kam Man Hui, Gautam Sethi, Yeong Shik Kim
Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway. Cancers 13 (21) (2021)
Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi, Alan Prem Kumar
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells 10 (12) (2021)
Chakrabhavi Dhananjaya Mohan, Chulwon Kim, Kodappully Sivaraman Siveen, Kanjoormana Aryan Manu, Shobith Rangappa, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Kanchugarakoppal S Rangappa, Alan Prem Kumar, Yeong Shik Kim
Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma. IUBMB life 73 (11) (2021)
Ted Kheng Siang Ng, Lei Feng, Johnson Fam, Iris Rawtaer, Alan Prem Kumar, Grishma Rane, Irwin Kee-Mun Cheah, Ratha Mahendran, Yuan Kun Lee, Ene Choo Tan, Lee Gan Goh, Ee Heok Kua, Rathi Mahendran
Mindfulness Awareness Practice (MAP) to Prevent Dementia in Older Adults with Mild Cognitive Impairment: Protocol of a Randomized Controlled Trial and Implementation Outcomes. International journal of environmental research and public health 18 (19) (2021)
Kumar Rishabh, Soham Khadilkar, Aviral Kumar, Ishu Kalra, Alan Prem Kumar, Ajaikumar B Kunnumakkara
MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review. International journal of molecular sciences 22 (5) (2021)
Sun Tae Hwang, Min Hee Yang, Alan Prem Kumar, Gautam Sethi, Yeong Shik Kim
Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade. Biomolecules 10 (10) (2020)
Milad Ashrafizadeh, Kiavash Hushmandi, Mehrdad Hashemi, Mohammad Esmaeil Akbari, Peter Kubatka, Mehdi Raei, Lenka Koklesova, Md Shahinozzaman, Reza Mohammadinejad, Masoud Najafi, Gautam Sethi, Alan Prem Kumar, Ali Zarrabi
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules 10 (8) (2020)
Milad Ashrafizadeh, Masoud Najafi, Hui Li Ang, Ebrahim Rahmani Moghadam, Mahmood Khaksary Mahabady, Amirhossein Zabolian, Leila Jafaripour, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hossein Saleki, Ali Zarrabi, Alan Prem Kumar
PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines 8 (8) (2020)
Choudhary Harsha, Kishore Banik, Hui Li Ang, Sosmitha Girisa, Rajesh Vikkurthi, Dey Parama, Varsha Rana, Bano Shabnam, Elina Khatoon, Alan Prem Kumar, Ajaikumar B Kunnumakkara
Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. International journal of molecular sciences 21 (9) (2020)
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hui Li Ang, Pooyan Makvandi, Haroon Khan, Alan Prem Kumar
Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics 12 (11) (2020)
Young Yun Jung, Jae-Young Um, Acharan S Narula, Ojas A Namjoshi, Bruce E Blough, Alan Prem Kumar, Yeong Shik Kim
Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells. International journal of molecular sciences 21 (13) (2020)
Ebrahim Rahmani Moghadam, Hui Li Ang, Sholeh Etehad Asnaf, Amirhossein Zabolian, Hossein Saleki, Mohammad Yavari, Hossein Esmaeili, Ali Zarrabi, Milad Ashrafizadeh, Alan Prem Kumar
Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 10 (10) (2020)
Milad Ashrafizadeh, Hui Li Ang, Ebrahim Rahmani Moghadam, Shima Mohammadi, Vahideh Zarrin, Kiavash Hushmandi, Saeed Samarghandian, Ali Zarrabi, Masoud Najafi, Reza Mohammadinejad, Alan Prem Kumar
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 10 (7) (2020)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Ru-Mei Chen, Yi-Shiou Chiou, Qing-Yun Chong, Han-Ming Poh, Tuan-Zea Tan, Meng-Yi Zhang, Lan Ma, Tao Zhu, Vijay Pandey, null Basappa, Alan Prem Kumar, Peter E Lobie
Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK. International journal of molecular sciences 20 (24) (2019)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Jong Hyun Lee, Chakrabhavi Dhananjaya Mohan, Salundi Basappa, Shobith Rangappa, Arunachalam Chinnathambi, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Alan Prem Kumar, Gautam Sethi, Yeong Shik Kim, Kanchugarakoppal S Rangappa
The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells. Biomolecules 9 (12) (2019)
Ekta Khattar, Kyaw Ze Ya Maung, Chen Li Chew, Arkasubhra Ghosh, Michelle Meng Huang Mok, Pei Lee, Jun Zhang, Wei Hong Jeff Chor, Gökhan Cildir, Chelsia Qiuxia Wang, Nur Khairiah Mohd-Ismail, Desmond Wai Loon Chin, Soo Chin Lee, Henry Yang, Yong-Jae Shin, Do-Hyun Nam, Liming Chen, Alan Prem Kumar, Lih-Wen Deng, Masahito Ikawa, Jayantha Gunaratne, Motomi Osato, Vinay Tergaonkar
Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy. Nature communications 10 (1) (2019)
Han Ming Poh, Yi Shiou Chiou, Qing Yun Chong, Ru-Mei Chen, Kanchugarakoppal S Rangappa, Lan Ma, Tao Zhu, Alan Prem Kumar, Vijay Pandey, null null, Soo-Chin Lee, Peter E Lobie
Inhibition of TFF3 Enhances Sensitivity-and Overcomes Acquired Resistance-to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma. Cancers 11 (10) (2019)
Bethsebie Lalduhsaki Sailo, Kishore Banik, Sosmitha Girisa, Devivasha Bordoloi, Lu Fan, Clarissa Esmeralda Halim, Hong Wang, Alan Prem Kumar, Dali Zheng, Xinliang Mao, Gautam Sethi, Ajaikumar Bahulayan Kunnumakkara
FBXW7 in Cancer: What Has Been Unraveled Thus Far? Cancers 11 (2) (2019)
Lingzhi Wang, Do-Dang Khoa Phan, Nicholas Syn, Xiaoqiang Xiang, Hongyan Song, Win Lwin Thuya, Shili Yang, Andrea Li-Ann Wong, Alan Prem Kumar, Wei Peng Yong, Gautam Sethi, Paul Chi-Lui Ho, Boon Cher Goh
A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nimbolide in Mouse Serum: Application to a Preclinical Pharmacokinetics Study. Pharmaceutics 10 (3) (2018)
Devivasha Bordoloi, Kishore Banik, Bano Shabnam, Ganesan Padmavathi, Javadi Monisha, Frank Arfuso, Arunasalam Dharmarajan, Xinliang Mao, Lina H K Lim, Lingzhi Wang, Lu Fan, Kam Man Hui, Alan Prem Kumar, Gautam Sethi, Ajaikumar B Kunnumakkara
TIPE Family of Proteins and Its Implications in Different Chronic Diseases. International journal of molecular sciences 19 (10) (2018)
Abhishek Manoj Ranaware, Kishore Banik, Vishwas Deshpande, Ganesan Padmavathi, Nand Kishor Roy, Gautam Sethi, Lu Fan, Alan Prem Kumar, Ajaikumar B Kunnumakkara
Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer. International journal of molecular sciences 19 (8) (2018)
Andrea Li-Ann Wong, Xiaoqiang Xiang, Pei Shi Ong, Ee Qin Ying Mitchell, Nicholas Syn, Ian Wee, Alan Prem Kumar, Wei Peng Yong, Gautam Sethi, Boon Cher Goh, Paul Chi-Lui Ho, Lingzhi Wang
A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs. Pharmaceutics 10 (4) (2018)
Javadi Monisha, Nand Kishor Roy, Ganesan Padmavathi, Kishore Banik, Devivasha Bordoloi, Amrita Devi Khwairakpam, Frank Arfuso, Arunachalam Chinnathambi, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Gautam Sethi, Alan Prem Kumar, Ajaikumar B Kunnumakkara
NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance. Cancers 10 (7) (2018)
Loukik Arora, Alan Prem Kumar, Frank Arfuso, Wee Joo Chng, Gautam Sethi
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies. Cancers 10 (9) (2018)
Gurubharathi Bhuvanalakshmi, Naisarg Gamit, Manasi Patil, Frank Arfuso, Gautam Sethi, Arun Dharmarajan, Alan Prem Kumar, Sudha Warrier
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma. Cancers 11 (1) (2018)
Mei S Ong, Wanpei Cai, Yi Yuan, Hin C Leong, Tuan Z Tan, Asad Mohammad, Ming L You, Frank Arfuso, Boon C Goh, Sudha Warrier, Gautam Sethi, Nicholas S Tolwinski, Peter E Lobie, Celestial T Yap, Shing C Hooi, Ruby Y Huang, Alan Prem Kumar
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling. British journal of pharmacology 174 (24) (2017)